Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1028 | 1004 | 1023 | 1028 | 1421 | 2173 |
Fund Return | 2.81% | 0.42% | 2.31% | 0.92% | 7.28% | 8.07% |
Place in category | 377 | 462 | 413 | 290 | 85 | 23 |
% in Category | 83 | 95 | 92 | 71 | 23 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Eurose Class AD shares | 2.45B | 1.54 | 3.10 | 2.01 | ||
DNCA Invest Eurose Class A shares | 2.45B | 1.54 | 3.10 | 2.01 | ||
DNCA Invest Eurose Class I shares E | 2.45B | 1.78 | 3.84 | 2.75 | ||
DNCA Invest Europe Growth Class A s | 1.27B | 2.95 | 1.30 | 8.46 | ||
DNCA Invest Europe Growth Class F s | 1.27B | 3.37 | 2.49 | 9.60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 1.27B | 2.95 | 1.30 | 8.46 | ||
DNCA Invest Europe Growth Class F s | 1.27B | 3.37 | 2.49 | 9.60 | ||
DNCA Invest Europe Growth Class I s | 1.27B | 3.30 | 2.30 | 9.46 | ||
LU1330191385 | 1.01B | 5.17 | 12.41 | - | ||
BlackRock European Opp Extension X2 | 712.98M | 6.08 | 9.22 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 9.61 | 917.9 | +0.87% | |
ASML Holding | NL0010273215 | 6.46 | 848.30 | +0.90% | |
Edenred | FR0010908533 | 5.15 | 47.99 | +0.33% | |
Schneider Electric | FR0000121972 | 4.59 | 234.55 | +0.39% | |
Gaztransport et Technigaz SA | FR0011726835 | 4.21 | 135.10 | +0.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review